David P. Ward

Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.

Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA.

Micell Technologies, Inc. operates as a biomedical device company. It develops interventional cardiology systems for vascular drug delivery. The firm offers MiStent SES is designed to optimize healing in patients with coronary artery disease. The company was founded by Joseph M. DeSimone and James B. McClain in 1995 and is headquartered in Durham, NC.

AEGEA Medical, Inc. develops technology that utilizes convective water vapor to treat menorrhagia. The firm focuses on the development of its proprietary and innovative water vapor treatment for abnormal uterine bleeding. It has vapor system delivers controlled, low-pressure natural water vapor to the uterine cavity to efficiently ablate the inner lining of the uterus. The company was founded by Paul M. Goeld in 2008 and is headquartered in Redwood City, CA.

Knopp Biosciences LLC engages in the operation of a drug discovery and development company. It offers dexpramipexole product, an orally bioavaliable small molecule in development treatment of asthma, eosinophil-associated disorders and amyotrophic lateral sclerosis (ALS) disease. The company was founded by Robert Bowser and Gregory T. Hebrank in 2004 and is headquartered in Pittsburgh, PA.

Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN.

EnviCor Enterprises LLC designs and manufactures plastic molders. It offers custom molders for the manufacture of paddle boards, barrels, plastic containers, septic equipment and water tanks. The company was founded by G. Steve Arnold in 2006 and is headquartered in Smithfield, NC.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Braintree Laboratories, Inc. manufactures pharmaceutical products and drugs. Its products include SUPREP, NuLYTELY and GoLYTELY. The company was founded by Harry Keegan III and Reinier Beeuwkes in 1982 and is headquartered in Braintree, MA.

Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA.

National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD.

The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia.

The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC.

Lineberry Research Associates LLC operates as a contract research and consulting company, offers drug research, development, and marketing services to pharmaceutical and biotechnology companies. Its services include strategic consulting, clinical research and regulatory affairs, scientific writing and communications. The company was founded in July 1995 by Cathy Frieden Lineberry and is headquartered in Research Triangle Park, NC.

Life Science Tennessee operates tennessee biotechnology association. It conducts business and economic development activities. The firm advocates on behalf of the industry. It provides a network for the exchange of ideas, information and opportunities. The company is headquartered in Nashville, TN.

Council for Entrepreneurial Development provides an interactive forum for entrepreneurs, investors, service professionals, academicians, researchers and public policy makers. Its services and programs include connections to capital, venture mentoring, and signature conferences empower member companies to go further. The company was founded in 1984 and is headquartered in Durham, NC.

NX Prenatal, Inc. is amolecular diagnostics company, which engages in the development of diagnostic assays for adverse pregnancy conditions such as preterm birth. The company was founded by Gail S. Page and Brian D. Brohman and is headquartered in Louisville, KY.

Solas BioVentures (mayfield) LLC (Solas BioVentures) is a venture capital firm founded in 2012 by David Adair and Mark Hackett JD. The firm is headquartered in Chattanooga, Tennessee.

Elira, Inc. develops a system to suppress appetite and assist diet adherence. The company was founded by John Faul in 2015 and is headquartered in St. Louis, MO.

TARGET Pharmasolutions, Inc. operates as a real-world data solutions company. It specializes in nonalcoholic steatohepatitis, hepatocellular carcinoma, inflammatory bowel disease, and primary biliary cholangitis. The company was founded by Margaret Powell and Michael W. Fried in February 2015 and is headquartered in Chapel Hill, NC.

Arrivo Management LLC is a biopharmaceutical company. It develops biologics and small molecules to improve patient lives. The company was founded by Steve Butts, Bill Wofford, Michael Ackermann and Jed Black on July 9, 2015 and is headquartered in Morrisville, NC.

Stimdia Medical, Inc. engages in operates clinics and health care centers. The company is headquartered in Edina, MN.

Emergo Therapeutics, Inc. provides pharmaceuticals services. The company was founded by Robin Hyde-DeRuyscher and is headquartered in Durham, NC.

Francis Medical, Inc. develops an innovative and patented vapor ablation therapy to treat a variety of endourological cancers, beginning with prostate cancer. The company was founded by Michael F. Hoey and is headquartered in Maple Grove, MN.

EirSystems, Inc. develops an e-Prescribing portal. It offers P.A.G.R. Prescriptions, advanced platform that will allow physicians and pharmacists to utilize built-in tools that make the prescribing process simpler, safer, and more efficient. The company was founded by Tyler Seaberg and Ryan Seaberg and is headquartered in Chattanooga, TN.

Valanbio Therapeutics, Inc. engages in the business of pharmaceuticals industry. The company is headquartered in Raleigh, NC.

Intershunt Technologies, Inc. is a medical device company based in Plymouth, MN. The company is developing a proprietary catheter system that allows for the capture and excision of tissue from the interatrial septum. This results in a left to right atrial shunt that off-loads elevated left atrial pressure, reducing symptoms in heart failure patients. The mechanical system is designed for safety and ease of use and is the only interatrial shunting device that requires no implant and no energy. The company was founded by Gil Vardi and the CEO is Harlee L. Sorkin.

Pretel, Inc. engages in the provision of pregnancy monitoring solutions called area sensor uterine electromyography (uEMG). Its solutions solves the inability of existing technology to accurately identify independent contraction activity of individual regions of the uterus. The firms regional uterine monitoring results include supports preterm labor management; accurate antepartum assessment; labor progress information; safely conducts induction therapy; measure regional uterine synchronization; evaluates progress of labor; and additional observations and measurement. The company was founded by Roger Young and is headquartered in Chattanooga, TN.

QuatroBio LLC engages in drug development services. The company was founded by Moise A. Khayrallah on September 4, 2014 and is headquartered in Morrisville, NC.

Anogen Life Sciences, Inc. provides biotechnology services. The CEO of the American company is Steven B. Bettis.

Veranex, Inc. is a tech-enabled service provider that offers a comprehensive platform for the medtech industry. The company is based in Raleigh, NC and has subsidiaries in Sweden, Switzerland, United States, and United Kingdom. The company provides expert guidance for engineering and design, clinical, market access, and regulatory services, enabling accelerated speed to market, controlled development costs, and development risk mitigation. Veranex's holistic approach ensures that all key functional areas are addressed with the highest level of expertise and attention to detail, making it a trusted partner for companies of all sizes. The company was founded in 2021, and Patrick K. Donnelly has been the CEO of the company since 2021.

Oculi, Inc. is a semiconductor company. The company is based in Baltimore, MD. The company was founded by Charbel Rizk. Charbel Rizk has been the CEO since incorporation.

Areteia Therapeutics, Inc. is a clinical stage biotechnology company that focuses on developing and delivering novel inflammation and immunology therapies for respiratory patients. The company is based in Short Hills, NJ, and the CEO of the company is Jorge Bartolome. The company's initial focus is on developing the first potential oral drug for eosinophilic asthma, with its lead drug candidate being dexpramipexole, a first-in-class oral eosinophil maturation inhibitor. Areteia was created by Population Health Partners and Knopp Biosciences, and a syndicate of leading life sciences and strategic investors has committed to investing up to $350 million in series A financing to establish Areteia and advance dexpramipexole through phase III clinical trials.